EQUASENS (EQS.PA) Stock Price, Quote, News and Overview
EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
EQS.PA Quote, Performance and Key Statistics
EQUASENS
EPA:EQS (2/4/2025, 7:00:00 PM)
36.6
+0.1 (+0.27%)
The current stock price of EQS.PA is 36.6 EUR. In the past month the price decreased by -13.27%. In the past year, price decreased by -23.43%.
EQS.PA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEE.DE | VEEVA SYSTEMS INC-CLASS A | 37.14 | 36.66B | ||
| COP.DE | COMPUGROUP MEDICAL SE & CO K | 47.58 | 1.23B | ||
| NXU.DE | NEXUS AG | 44.26 | 1.18B | ||
| CONTX.OL | CONTEXTVISION AB | 18.14 | 393.04M | ||
| GPI.MI | GPI SPA | 3 | 276.67M | ||
| CGM.PA | CEGEDIM SA | 80 | 169.20M | ||
| AGFB.BR | AGFA-GEVAERT NV | N/A | 138.25M | ||
| ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 61.94M | ||
| M3V.DE | MEVIS MEDICAL SOLUTIONS AG | N/A | 46.96M | ||
| AJ91.DE | DOCCHECK AG | 18.65 | 45.38M | ||
| ALINS.PA | INTRASENSE SAS | N/A | 14.21M |
Related stock screener links
About EQS.PA
Company Profile
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est and currently employs 1,240 full-time employees. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );
Company Info
EQUASENS
5 Allee de Saint-Cloud
Villers-les-Nancy GRAND EST FR
Employees: 1240
Company Website: https://equasens.com/
Investor Relations: https://equasens.com/investisseurs/
Phone: 33383159595
EQS.PA FAQ
What is the stock price of EQS.PA?
The current stock price of EQS.PA is 36.6 EUR.
What is the symbol for EQUASENS stock?
The exchange symbol of EQUASENS is EQS and it is listed on the Euronext Paris - Matif exchange.
On which exchange is EQS.PA stock listed?
EQS.PA stock is listed on the Euronext Paris - Matif exchange.
Is EQS.PA a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for EQS.PA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of EQS.PA.
Does EQS.PA stock pay dividends?
EQS.PA has a dividend yield of 3.39%. The yearly dividend amount is currently 1.15.
When does EQS.PA stock report earnings?
EQS.PA will report earnings on 2025-02-06, after the market close.
What is the Price/Earnings (PE) ratio of EQS.PA?
The PE ratio for EQS.PA is 11.81. This is based on the reported non-GAAP earnings per share of 3.1 and the current share price of 36.6 EUR.
EQS.PA Technical Analysis
EQS.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA. EQS.PA scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
EQS.PA Financial Highlights
Over the last trailing twelve months EQS.PA reported a non-GAAP Earnings per Share(EPS) of 3.1. The EPS decreased by 1.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 21.42% | ||
| ROA | 11.94% | ||
| ROE | 21.46% | ||
| Debt/Equity | 0.2 |
EQS.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to EQS.PA. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of -27.4% and a revenue growth -5.14% for EQS.PA